Clevius Curry
Hematology & Oncology · Scottsdale, AZNPI 1487989927
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 95.2% of the total across 171 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 38 manufacturers, the largest accounting for just 14.5% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $1,131 and has fallen 98.0% since, to $23 in 2023. That places this record below the midpoint for hematology & oncology clinicians in AZ, where the typical reported total is $6,870.
Across 171 payments — averaging $16.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$409
- AstraZeneca$279
- Amgen$236
- Genentech USA, Inc.$221
- Merck$156
- Seagen Inc.$113
- plus $1K from 32 others
What the payments were for
- Food & beverage$2,67795%
- Education$1365%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 27 | $409 |
| AstraZeneca(2 entities) | 18 | $279 |
| Amgen | 13 | $236 |
| Genentech USA, Inc. | 8 | $221 |
| Merck | 10 | $156 |
| Seagen Inc. | 8 | $113 |
| Bayer | 5 | $92 |
| Lilly USA, LLC | 6 | $79 |
| AbbVie | 5 | $77 |
| Eisai Inc. | 5 | $71 |
| Incyte Corporation | 4 | $70 |
| Gilead | 3 | $64 |
| EMD Serono, Inc. | 4 | $64 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $62 |
| Astellas Pharma US Inc | 4 | $61 |
| Puma Biotechnology, Inc. | 4 | $61 |
| E.r. Squibb & Sons, L.L.C. | 3 | $59 |
| Regeneron Healthcare Solutions, Inc. | 3 | $57 |
| Johnson & Johnson | 3 | $50 |
| Daiichi Sankyo Inc. | 3 | $46 |
| Myriad Genetic Laboratories, Inc. | 3 | $44 |
| Pharmacyclics LLC, An Abbvie Company | 3 | $43 |
| Sanofi | 2 | $41 |
| Dova Pharmaceuticals | 3 | $40 |
| Karyopharm Therapeutics Inc. | 2 | $36 |
| Rigel Pharmaceuticals, Inc. | 2 | $35 |
| Coherus Oncology, Inc. | 2 | $30 |
| Pfizer | 2 | $28 |
| Teva Pharmaceuticals USA, Inc. | 2 | $28 |
| Kyowa Kirin, Inc. | 2 | $28 |
| Myovant Sciences Inc. | 1 | $24 |
| Boehringer Ingelheim | 1 | $20 |
| Epizyme, Inc. | 1 | $19 |
| Pharmacosmos Therapeutics Inc. | 1 | $17 |
| GSK | 1 | $15 |
| Clovis Oncology, Inc. | 1 | $14 |
| AMAG Pharmaceuticals, Inc. | 1 | $12 |
| Global Blood Therapeutics, Inc. | 1 | $11 |
How this compares
$2,814 in reported general payments places this provider in the 35th percentile of 261 hematology & oncology providers in Arizona.
Other hematology & oncology in Scottsdale
- Jeffrey SchriberScottsdale$715K
- Tanios Bekaii-SaabScottsdale$527K
- Rajesh KukunoorScottsdale$499K
- Yousef ZakhariaScottsdale$214K
- Thai HoScottsdale$190K
- Alan BryceScottsdale$157K
- Daniel AhnScottsdale$91K
- Brendan CurleyScottsdale$87K
- Alexander StewartScottsdale$76K
- Saurabh ChhabraScottsdale$68K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.